Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Major Medical Organizations Establish Ambitious Diabetes Registry
Forbes
Wednesday, June 11, 2014 - 9:04am
tags:
diabetes
Federal views diverge on proper use of painkillers
Yahoo/AP
Wednesday, June 11, 2014 - 9:03am
tags:
painkillers, hydrocodone, FDA
Diabetic Treatment Cost Doubles as Insulin Use Increases
Bloomberg
Tuesday, June 10, 2014 - 8:16pm
tags:
insulin, diabetes
Valeant plans hostile bid after Allergan board unanimously rebuffs latest acquisition offer
Yahoo/AP
Tuesday, June 10, 2014 - 7:23pm
tags:
hostile bid, Allergan, M&A, Valeant Pharmaceuticals
IPO Stock Watch: Receptos Soars On MS Drug Results
Investors.com
Tuesday, June 10, 2014 - 7:22pm
tags:
IPOs, MS, multiple sclerosis, Receptos, RPC1063, Novartis, Gilenya
Intuitive Wins Trial, Defeats Negligent Training Claims
Bloomberg
Tuesday, June 10, 2014 - 7:20pm
tags:
robot-assisted surgery, Intuitive Surgical, devices
Merck's Acquisition Of Idenix Pharmaceuticals Is An Admission Of Inferiority To Sovaldi Regimens
Seeking Alpha
Tuesday, June 10, 2014 - 7:19pm
tags:
Idenix, Merck, M&A, hepatitis C, Sovaldi, Gilead Sciences
How Many? Novartis Says 10,000 Side Effect Cases Were Never Filed
WSJ Online
Tuesday, June 10, 2014 - 4:49pm
tags:
side effects, adverse events, Novartis, Japan
China Pharma Industry Rises to the Occasion as Viagra Patent Expires
TheStreet.com
Tuesday, June 10, 2014 - 4:45pm
tags:
China, Viagra, patents, erectile dysfunction
Dendreon's CEO Exits: Is this the Beginning of the End?
Motley Fool
Tuesday, June 10, 2014 - 4:42pm
tags:
Dendreon, Pharma CEOs, John Johnson, Provenge
Medtronic confirms Corventis buy, expects to close this month
Mass Device
Tuesday, June 10, 2014 - 11:00am
tags:
Medtronic, Corventis, M&A, devices
BioDelivery Sciences: After FDA Approval, Still Room To Run
Seeking Alpha
Tuesday, June 10, 2014 - 10:55am
tags:
FDA, BioDelivery Sciences, Bunavail, opioid addiction
Free Speech or Bribes? Feds Wrestle With Allergan Over Advice Given Docs
WSJ Online
Tuesday, June 10, 2014 - 10:54am
tags:
free speech, Allergan, physicians
Apple’s talks with the FDA provide further evidence for a wearable device
Yahoo/Gigaom
Tuesday, June 10, 2014 - 10:49am
tags:
FDA, Apple, devices
Allergan Board Rejects Valeant’s Latest $54 Billion Bid
Bloomberg
Tuesday, June 10, 2014 - 10:43am
tags:
Allergan, Valeant Pharmaceuticals, M&A
BrainStorm Expands Pipeline With Initiation of Pre-Clinical Study in Autism
Yahoo
Tuesday, June 10, 2014 - 10:41am
tags:
BrainStorm Cell Therapeutics, autism, stem cells
Aeterna Zentaris announces workforce reduction and optimization program
Yahoo/Fly on the Wall
Tuesday, June 10, 2014 - 10:40am
tags:
Aeterna Zentaris, layoffs
AstraZeneca: Pfizer Wants It, So Should You
Seeking Alpha
Tuesday, June 10, 2014 - 10:38am
tags:
Pfizer, AstraZeneca, Novartis, Teva Pharmaceuticals, M&A
Achillion Hep C Drug Update is Well Timed
TheStreet.com
Tuesday, June 10, 2014 - 9:54am
tags:
Achillion, hepatitis C, sovaprevir, Merck, Idenix
Biopharmaceutical Industry Consolidation Diminishes Future Drug Discovery
Forbes
Tuesday, June 10, 2014 - 9:38am
tags:
R&D, M&A, Pfizer, Wyeth, GSK, Novartis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.